A retrospective analysis from a single center for 60 COVID-19 patients with asymptomatic, mild to moderate, and severe conditions in Wuxi, China

被引:0
|
作者
Huang, Jiehui [1 ]
Qian, Chao [1 ]
Bian, Tao [1 ]
Chu, Meiping [1 ]
Yin, Weiwei [1 ]
Pang, Yonghua [1 ]
Bai, Jinmei [1 ]
Huang, Yanjie [1 ]
机构
[1] Fifth Peoples Hosp Wuxi, Dept Resp Med, 1215 Guangrui Rd, Wuxi 214000, Jiangsu, Peoples R China
关键词
COVID-19; CRP; different severity; immune indices; retrospective study;
D O I
10.1097/MD.0000000000026748
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to retrospectively analyze the clinical data of COVID-19 patients with different severity during February 2020 in Wuxi, China. The present retrospective study included a total of 60 cases who were diagnosed as COVID-19 patients and hospitalized in the Wuxi Fifth People's Hospital during February 2020 to March 2020. Among all patients 14 cases were asymptomatic, 25 cases were with mild stage, 13 cases were with moderate stage, and 8 cases were with severe stage. Basic clinical data as well as clinical characteristics, including temperature, respiratory rate, heart rate, blood gas analysis data, whole blood test data, and the prognosis condition, were collected and analyzed. Statistical analysis was conducted in different severity stage patients. Among the patients, the median temperature gradually increased from the asymptomatic to the severe patients and the median age increased from the mild to the severe patients with statistical difference. The hospitalization duration was the highest in severe patients. Higher heart rate, as well as lower oxygen partial pressure and oxygenation index were observed in severe patients than the other groups. Besides, higher CRP and globulin levels after admission were found in severe patients, and were gradually increased from the asymptomatic patients to the severe patients. On the contrary, the lymphocyte ratio and count was significant lower in severe patients. We also observed higher D-Dimer levels in the severe patients and the difference was statistical. Among all patients, 2 cases (3.33%) died and other patients were all cured after treatment. Statistical difference was mainly found mainly in age, hospitalization duration, temperature, CRP levels, O-2 partial pressure and oxygenation index, globulin, lymphocyte ratio, and D-Dimer in patients with different severity. The higher CRP levels, lower O-2 partial pressure and oxygenation index, higher globulin, lower lymphocyte ratio, and higher D-Dimer might be associated with the patients' severity.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Efficacy of Tocilizumab in Patients with a Moderate and Severe COVID-19: A Retrospective Single Center Cohort Study
    Bolukcu, Sibel
    KarakuS, Dilara
    Okay, Gulay
    Akkoyunlu, Yasemin
    Sumbul, Bilge
    Durdu, Bulent
    Koc, Meliha Meric
    Aslan, Turan
    [J]. MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2021, 10
  • [2] Asymptomatic olfactory dysfunction in nonintubated patients with moderate and severe COVID-19
    Mata-Mendoza, Patricia
    Delgado-Garcia, Guillermo
    Gonzalez-Munoz, Alejandro
    Antonio Fernandez-Vera, Jose
    [J]. NEUROLOGY, 2021, 96 (15)
  • [3] Risk factors for mortality in hospitalized moderate-to-severe COVID-19 patients: A single-center retrospective study
    Bahadorizadeh, Leyla
    Fard, Soheil Rahmani
    Behnagh, Arman Karimi
    Kiapey, Seyed Ali Hashemi
    Saneii, Seyed Hassan
    Minaeian, Sara
    [J]. INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2021, 8 (04) : 267 - +
  • [4] The importance of overweight in COVID-19 A retrospective analysis in a single center of Wuhan, China
    Rao, Xinrui
    Wu, Chuangyan
    Wang, Sihua
    Tong, Song
    Wang, Geng
    Wu, Gang
    Zhou, Rui
    [J]. MEDICINE, 2020, 99 (43): : E22766
  • [5] Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience
    Amanam, Idoroenyi
    Yao, Janny
    Puing, Alfredo
    Tsai, Ni-Chun
    Samuels, Diana
    Ngo, Dat
    Ho, Stephanie
    Ali, Haris
    Aribi, Ahmed
    Arslan, Shukaib
    Artz, Andrew
    Htut, Myo
    Koller, Paul
    Salhotra, Amandeep
    Sandhu, Karamjeet
    Nikolaenko, Liana
    Pawlowska, Anna
    Shouse, Geoffrey
    Stein, Anthony
    Marcucci, Guido
    Forman, Stephen
    Nakamura, Ryotaro
    Dadwal, Sanjeet
    Al Malki, Monzr M. M.
    [J]. CANCER MEDICINE, 2023, 12 (10): : 11248 - 11253
  • [6] Olfactory Dysfunction in Mild-Moderate-Severe COVID-19 Patients
    Tuzun, Kemal
    Abes, Derya
    [J]. B-ENT, 2022, 18 (01) : 59 - 66
  • [7] Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
    Mastroianni, Antonio
    Vangeli, Valeria
    Chidichimo, Luciana
    Urso, Filippo
    De Marco, Giuseppe
    Zanolini, Alfredo
    Greco, Francesca
    Mauro, Maria, V
    Greco, Sonia
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [8] Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19: a Single-Center, Retrospective Study
    Soma, Tomomi
    Fujii, Kentaro
    Yoshifuji, Ayumi
    Maruki, Taketomo
    Itoh, Kazuto
    Taniyama, Daisuke
    Kikuchi, Takahide
    Hasegawa, Naoki
    Nakamura, Morio
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (05) : 484 - 489
  • [9] COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China
    Li, Jiayi
    Zheng, Yiming
    Zhao, Yawen
    Qi, Kang
    Lin, Gang
    Liu, Ran
    Hao, Hongjun
    Wang, Zhaoxia
    Yuan, Yun
    Gao, Feng
    [J]. NEUROLOGICAL SCIENCES, 2024, 45 (07) : 2969 - 2976
  • [10] A Retrospective Single-Center Analysis of COVID-19 Patients with Fatal Outcome
    Gashynova, K.
    But, N.
    Rudakova, V.
    Suska, K.
    Dmytrychenko, V.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205